Tag Archives: FNSR

Hot Performing Stocks To Watch For 2023

With the S&P 500 Index surpassing 4,500 points, it is time to take a look at one of its well-performing sectors, which is Consumer Loans. Performance of the Zacks Consumer Loans industry with a year-to-date return of 48.1% is turning out to be impressive. Over the same time frame, the S&P 500 Index has rallied 21.8%.

The Zacks Consumer Loans industry is a 19-stock group within the broader Zacks Finance sector. The industry currently carries a Zacks Industry Rank #57, which places it in the top 23% of more than 250 Zacks industries.

Although last year, the pandemic had....More>>>

Best Value Stocks To Invest In Right Now

New York, NY, based Investment company Standard General L.P. buys Turning Point Brands Inc during the 3-months ended 2018-03-31, according to the most recent filings of the investment company, Standard General L.P.. As of 2018-03-31, Standard General L.P. owns 4 stocks with a total value of $89 million. These are the details of the buys and sells.

Added Positions: NCMI, TPB,

For the details of Standard General L.P.’s stock buys and sells, go to www.gurufocus.com/StockBuy.php?GuruName=Standard+General+L.P.

These are the top 5 holdings of Standard General L.P.National....More>>>

Top 10 Tech Stocks To Own For 2019

Ascendis Pharma (NASDAQ:ASND) caught my eye earlier this year when I was looking at quarterly ownership changes of biotech-focused hedge funds. Many funds were aggressively buying Ascendis over the last few quarters, and the stock is a high conviction name for at least a few of them. However, the stock was up more than 50% at that point, and I decided to put it aside as there were no material catalysts during most of 2017 and wait for some form of a consolidation or a pullback before doing more research. The stock was in consolidation mode for more than six months and broke out in late September....More>>>

Best Undervalued Stocks To Buy Right Now

As I said in a recent piece on PRA Health Sciences (NASDAQ:PRAH), there’s a lot to like about the contract research organization (or CRO) sector as trial complexity increases, R&D budgets continue to grow, and drug companies look to shift toward their specialties and more variable-expense models. Within this competitive space, INC Research (NASDAQ:INCR) has looked to stand out with an intense focus on Phase II-IV support, a greater skew towards smaller companies, and a more intense focus on a few specific therapeutic indications.

Whether this differentiated strategy will work....More>>>

Top 10 Tech Stocks To Buy For 2018

Related NUAN Watch These 8 Huge Put Purchases In Wednesday Trade Benzinga's Option Alert Recap From May 9
Related NBR Mid-Afternoon Market Update: LeMaitre Vascular Rises After Strong Q1 Results; Synchronoss Technologies Shares Plunge 20 Biggest Mid-Day Losers For Thursday

On CNBC's Fast Money Halftime Report, Jon Najarian spoke about high options activity in Nuance Communications Inc. (NASDAQ: NUAN). Traders were buying the June 19 calls for $1. The trade breaks even at $20....More>>>